Business Wire

Softr Unveils an AI-Native Platform, Ushering in a New Era of Business Software Creation Without Code

31.3.2026 13:00:00 CEST | Business Wire | Press Release

Share

Softr today evolved into an AI-native platform, marking the end of the AI prototype era and the beginning of production-ready business software that non-technical teams can build, own, and maintain with AI — without writing a single line of code. With the introduction of its new AI Co-Builder, Softr enables teams to replace spreadsheets and manual workflows with secure, fully-functional business applications, including internal tools, customer portals, partner platforms, and operational systems, simply by describing what they need.

This milestone marks a major evolution for Softr, a leading player in the no-code software category over the past five years. Since launching in 2020, the company has grown to support more than 1 million builders and 7,000 organizations, including Netflix, Google, Stripe, UPS, and Clay.

Softr’s new platform was built to bridge the gap between AI-generated prototypes and software that can actually run business operations. Many AI app builders promise instant software from a single prompt, but stop at surface-level outputs, requiring users to manage code, fix errors, and rebuild workflows from scratch. Business software, on the other hand, runs on real data, connects to internal systems, and supports users with defined roles and permissions in real time — it has to work 100 percent of the time. When AI builders fall short or stop at the prototype, only a developer can fix it — resulting in months of work and hundreds of thousands of dollars to get software that should have been ready on day one. Softr closes that gap.

Softr’s new AI-native platform enables organizations to move from fragmented tools to fully operational software systems built in minutes — designed to run securely on live data, integrate with internal infrastructure, and provide structured access and governance from day one.

“For the first time, AI made the idea that ‘I can build something myself’ mainstream for millions of people — but most AI app-builders stop at the shiny demo stage,” said Mariam Hakobyan, Co-Founder and CEO of Softr. “We built Softr to solve the hard parts of software building. Every business app, from an internal HR portal to a client-facing tool, runs on real data, users, permissions, and security. It has to work every single time. Our goal has always been to give non-technical teams the ability to build the custom solutions they need without relying on developers. This evolution turns that vision into reality: software that helps people build and run the mission-critical software that powers their business operations.”

With the addition of Softr’s AI Co-Builder, users can describe the software they need in plain language, and the platform generates a fully integrated system — including the database, user interface, permissions, and business logic — connected and ready for real-world users immediately. Core foundations such as authentication, user roles, permissions, and hosting are built in from the start, eliminating the need for teams to configure or manage them separately.

Softr’s platform is built for business software that teams and customers can depend on every day. Each application is:

  • Secure and fully functional from day one, with built-in authentication and permissions
  • Powered by a visual, user-friendly database, giving users full control over their data
  • Built on custom workflows and integrations, ensuring systems work seamlessly across tools
  • Easy to maintain and evolve, without requiring code or repeated prompting

Teams use Softr to power critical workflows such as client portals, CRMs, company intranets, and operational systems across a wide range of industries. The company is now combining that profitable foundation with AI to accelerate its mission: to empower billions of business users to create production-ready software they can rely on from day one.

“The future of software isn’t written — it’s created,” Hakobyan added. “The next generation of software will be built by everyone — not because we simplified code, but because we simplified creation — and made building hard things easy.”

About Softr

Softr is the AI-native platform for building the software your business runs on—portals, internal tools, and operational systems—without code or developers. Describe what you need, and AI creates the database, app, and business logic—already connected, secure, and ready for real users. Over 1M+ organizations, from startups to enterprises like Netflix, Google, Stripe, UPS, and Clay, run their business operations on Softr-built apps. Visit softr.io to learn more.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260331754358/en/

Contacts

PR Contact
Kristin Lunt
softr@solcomms.co

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press Release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.

Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press Release

Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press Release

2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press Release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press Release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye